(Q38227967)

English

A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes

scientific article published on 10 July 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 August 2017

0 references

A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes (English)

1 reference

Europe PubMed Central

31 August 2017

0 references

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Alexander McGirr

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25010396%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25010396%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25010396%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

M T Berlim

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25010396%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

M P Fleck

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25010396%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

L N Yatham

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25010396%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

0 references

publication date

10 July 2014

1 reference

Europe PubMed Central

31 August 2017

Psychological Medicine

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25010396%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

45

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25010396%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25010396%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

693-704

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25010396%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Glutamate-based antidepressants: 20 years on.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Functional impairment in the remission phase of bipolar disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Antidepressant effects of ketamine in depressed patients

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Ketamine as a novel antidepressant: from synapse to behavior

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Ketamine for depression: where do we go from here?

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Ketamine for treatment-resistant unipolar depression: current evidence

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Small-dose ketamine improves the postoperative state of depressed patients

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

An open-label trial of riluzole in patients with treatment-resistant major depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Functional antagonists at the NMDA receptor complex exhibit antidepressant actions

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

The file drawer problem and tolerance for null results

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Interpretation of random effects meta-analyses.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Serial infusions of low-dose ketamine for major depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

21 January 2018

A randomized controlled trial of intranasal ketamine in major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

7 January 2021

based on heuristic

inferred from DOI database lookup

Do the dissociative side effects of ketamine mediate its antidepressant effects?

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

7 January 2021

based on heuristic

inferred from DOI database lookup

Introduction to Meta-Analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS)

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001603

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38227967&oldid=1748268711"